The latest oncology news listed by date, covering all clinical focus areas, tumour types and more
Over more than 20 years, Professor Jonathan Cebon, former Medical Director of Cancer Services at…
“Even with notable progress in the treatment of metastatic renal cell carcinoma (RCC), there are…
“In the first Phase 3 randomised clinical trial for a KRASG12C inhibitor, oral sotorasib demonstrated…
A novel treatment strategy with personalised cell therapy significantly improves progression-free survival compared to standard…
Newly released results from the Phase III ADAURA trial reveal that osimertinib yielded a 5.5-year…
Cancer doctors, care providers and payers need to get ready for a major shift in…
A new mechanism has been identified through which very small pollutant particles in the air…
Significant improvement in progression free survival and response rate combined with reduced symptoms and better…
The Institute of Cancer Research, London, has expressed disappointment that NICE has confirmed its decision…
Implementing lung cancer screening at four diverse healthcare systems resulted in an 8.4 percent increase…